Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017
February 20 2017 - 4:05PM
GAITHERSBURG, Md., Feb. 20, 2017
(GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it
will report its fourth quarter and full year 2016 financial and
operating results following the close of U.S. financial markets on
Monday, February 27, 2017.
Conference call details are as follows:
Date: |
|
Monday, February 27, 2017 |
Time: |
|
4:30 p.m. U.S. Eastern Time
(ET) |
Dial-in number: |
|
(877) 212-6076 (Domestic) or
(707) 287-9331 (International) |
Passcode: |
|
61206704 |
Webcast: |
|
www.novavax.com, "Investors"/
"Events" |
|
|
|
Conference call and webcast replay:
Dates: |
|
Starting at 7:30 p.m. ET,
February 27, 2017, until midnight March 3, 2017 |
Dial-in number: |
|
(855) 859-2056 (Domestic) or
(404) 537-3406 (International) |
Passcode: |
|
61206704 |
Webcast: |
|
www.novavax.com, "Investors"/
"Events", until April 30, 2017 |
|
|
|
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage biotechnology company committed to delivering novel
products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for groundbreaking innovation that improves global
health through safe and effective vaccines.
Contact:
Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000
Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506
Media
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024